Findings from a large randomized clinical trial of household contacts helped get oral ensitrelvir approved for COVID-19 post-exposure prophylaxis in the U.S. and Japan.
NACI provides guidance on the use of quadrivalent meningococcal vaccines in routine and high-risk immunization programs for children under 2 years of age in Canada.
Two studies published simultaneously in the New England Journal of Medicine and the Lancet indicate that cefazolin and benzylpenicillin are safer alternatives that are just as effective as cloxacillin, which has been the standard treatment for decades.
Based on recent guidance from the National Advisory Committee on Immunization, all of the following are strongly recommended to receive TWO doses of COVID-19 vaccine per year, EXCEPT for . . .
The disease has sickened humans for thousands of years and wiped out a significant chunk of Europe’s population in the 14th century during what’s known as the Black Death. Though rare, the plague is still around today and is treated with antibiotics.
